TC
TRUFFLE CAPITAL SAS SAS BOARD MEMBER
Insider track record Other Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by TRUFFLE CAPITAL SAS SAS. Insider active across 2 companies, notably ABIVAX. In total, 22 disclosures have been published. Breakdown: 6 buys · 10 sells. Total volume traded: €26.9m. Activity tracked since 4 November 2021. The latest transaction was disclosed on 2 February 2026 (Acquisition). Regulator: AMF. All data is openly available.
Declarations 22 total
2,136,751 shares @ €2.34 25.9% of flow Action Acquisition hors marchéFR0013333077⌘ 2026DD1092720 Ideal exit: 30 Oct 2026 (T+270) 16,176 shares @ €1.36 0.1% of flow Action Acquisition hors marchéFR0013333077⌘ 2025DD1064624 Ideal exit: 17 Jul 2026 (T+270) 18,382 shares @ €1.36 0.1% of flow Action Acquisition hors marchéFR0013333077⌘ 2025DD1059546 Ideal exit: 17 Apr 2026 (T+270) ▼ Board Member · Executives · 2 Oct 2024 · ABIVAX 117,630 shares @ €9.0969 6.3% of flow Action Euronext ParisFR0012333284⌘ 2024DD999290 ▼ Board Member · Executives · 19 Sept 2024 · ABIVAX 35,000 shares @ €10.00 2.0% of flow Action Euronext ParisFR0012333284⌘ 2024DD996831 ▼ Board Member · Executives · 11 Sept 2024 · ABIVAX 41,270 shares @ €10.27 2.5% of flow Action Euronext ParisFR0012333284⌘ 2024DD995512 2,479,411 shares @ €1.38 17.8% of flow Titre de créance EuroclearFR0013333077⌘ 2024DD986552 1,419,871 shares @ €1.56 11.5% of flow Action Euronext ParisFR0013333077⌘ 2024DD949188 ▼ Board Member · Executives · 19 Dec 2023 · ABIVAX 75,000 shares @ €9.6667 4.2% of flow Action Euronext ParisFR0012333284⌘ 2023DD943554 ▼ Board Member · Executives · 11 Dec 2023 · ABIVAX 2,062 shares @ €9.40 0.1% of flow Action Euronext ParisFR0012333284⌘ 2023DD942355 ▲ Board Member · Executives · 20 Oct 2023 · ABIVAX 265,000 shares @ US$11.60 18.0% of flow Action Nasdaq Global MarketUS00370M1036⌘ 2023DD934753 Ideal exit: 16 Jul 2024 (T+270) ▼ Philippe Pouletty, Membre du conseil d'administration · Executives · 13 Jul 2023 · ABIVAX 16.088 shares @ €192,781.00 18.2% of flow Action Euronext ParisFR0012333284⌘ 2023DD920130 ▼ Board Member · Executives · 13 Jul 2023 · ABIVAX 192,781 shares @ €16.0881 18.2% of flow Action Euronext ParisFR0012333284⌘ 2023DD926614 ● Philippe Pouletty, Membre du conseil d'administration · Executives · 13 Jul 2023 · CARBIOS 129,427 shares @ €30.9055 99.4% of flow Action Euronext Growth ParisFR0011648716⌘ 2023DD920136 ▲ Board Member · Executives · 15 Jun 2023 · CARBIOS 627 shares @ €39.9195 0.6% of flow Action Euronext Growth ParisFR0011648716⌘ 2023DD915287 Ideal exit: 11 Mar 2024 (T+270) ▼ Board Member · Executives · 8 Jun 2023 · ABIVAX 224,729 shares @ €17.22 22.7% of flow Action Euronext ParisFR0012333284⌘ 2023DD914258 6,363,034 shares @ €1.32 43.6% of flow Action Euronext ParisFR0013333077⌘ 2023DD888174 6,363,034 shares @ €0.03 1.0% of flow BSAR Euronext ParisFR001400FL38⌘ 2023DD888175 ▼ Board Member · Executives · 6 Dec 2022 · ABIVAX 215,000 shares @ €6.2302 7.8% of flow Action Euronext ParisFR0012333284⌘ 2022DD875280 1,637,931 shares @ €2.32 100.0% of flow Action Euronext ParisFR0013333077⌘ 2022DD862308 ▲ Board Member · Executives · 2 Sept 2022 · ABIVAX 197,000 shares @ €8.36 33.7% of flow Action Euronext ParisFR0012333284⌘ 2022DD860537 Ideal exit: 30 May 2023 (T+270) ▼ Chairman of the Board · Executives · 4 Nov 2021 · ABIVAX 120,000 shares @ €27.00 66.3% of flow Action Euronext ParisFR0012333284⌘ 2021DD797396